Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome

Vincent Cottin, J. Le Pavec, G. Prévot, H. Mal, M. Humbert, G. Simonneau, Jean François Cordier, A. Berezné, D. Coëtmeur, I. Danner-Boucher, D. Funke, D. Israel-Biet, E. Marchand, L. Mouthon

Research output: Contribution to journalArticle

Abstract

This study aims to describe the haemodynamic and survival characteristics of patients with pulmonary hypertension in the recently individualised syndrome of combined pulmonary fibrosis and emphysema. A retrospective multicentre study was conducted in 40 patients (38 males; age 68±9 yrs; 39 smokers) with combined pulmonary fibrosis and emphysema, and pulmonary hypertension at right heart catheterisation. Dyspnoea was functional class II in 15%, III in 55% and IV in 30%. 6-min walk distance was 244±126 m. Forced vital capacity was 86±18%, forced expiratory volume in 1 s 78±19%, and carbon monoxide diffusion transfer coefficient 28±16% of predicted. Room air arterial oxygen tension was 7.5±1.6 kPa (56±12 mmHg). Mean pulmonary artery pressure was 40±9 mmHg, cardiac index 2.5±0.7 L·min -1·m -2 and pulmonary vascular resistance 521±205 dyn·s·cm -5. 1-yr survival was 60%. Higher pulmonary vascular resistance, higher heart rate, lower cardiac index and lower carbon monoxide diffusion transfer were associated with shorter survival. Patients with combined pulmonary fibrosis and emphysema syndrome and pulmonary hypertension confirmed by right heart catheterisation have a dismal prognosis despite moderately altered lung volumes and flows and moderately severe haemodynamic parameters. Copyright

Original languageEnglish
Pages (from-to)105-111
Number of pages7
JournalEuropean respiratory journal
Volume35
Issue number1
DOIs
Publication statusPublished - Jan 2010
Externally publishedYes

Keywords

  • Chronic obstructive pulmonary disease
  • Disproportionate
  • Emphysema
  • Pulmonary fibrosis
  • Pulmonary hypertension
  • Tobacco smoking

Fingerprint Dive into the research topics of 'Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome'. Together they form a unique fingerprint.

  • Cite this

    Cottin, V., Le Pavec, J., Prévot, G., Mal, H., Humbert, M., Simonneau, G., Cordier, J. F., Berezné, A., Coëtmeur, D., Danner-Boucher, I., Funke, D., Israel-Biet, D., Marchand, E., & Mouthon, L. (2010). Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. European respiratory journal, 35(1), 105-111. https://doi.org/10.1183/09031936.00038709